glp-1 agonist Frontiers GLP-1 Receptor Agonist Market Growth
Description
A.SchweizerA.MariA.NilssonP
Reddys Laboratories (DRL) and OneSource Specialty Pharma Ltd (OSSPL) from selling semaglutide in the domestic market follows a patent infringement claim initiated by Novo Nordisk
For subgroup analysis, the studies were classified based on whether the control group received metformin or placebo
2022;16 doi: 10.3389/fnins.2022.970925
For more information, refer to the full article in Anesthesia & Analgesia Pai SL, Nimma SR, Beam WB, et al
BioMed Pharmacother (2018) 108:95262
